Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
biomedical engineering is expected, including designing workstations for diagnostics, therapy and visual training, visual monitoring systems, and virtual training environments. Knowledge of human–machine
-
of these diseases as well as develop novel gene therapies using a variety of techniques and model systems. The position will involve work with rodent models, cell culturing, and in vitro experimental techniques
-
omics integration; CRISPR and advanced gene editing technologies; epigenetic profiling and modulation; biomarker discovery and validation; personalized therapeutic design; clinical decision support
-
, nanoparticle formulation, peptide therapeutics, T cells therapy, extracellular vesicles, cancer vaccines, brain cancer, motor neuron disease, protein corona, hydrogels, and gene therapy/editing. Hands
-
– Requisition #: 38516 Job Summary: Cell and gene therapies (CGTs) have recently demonstrated the potential to transform the treatment of patients with life-threatening and life-altering diseases. A major hurdle
-
About the Role Orion Pharma is making strategic investments in challenging R&D areas where our expertise can drive breakthroughs -particularly in cancer therapies. As part of this commitment, we
-
interests in neurodegenerative diseases. Previous research experience with epigenetics, neuron-glial interactions, neuroimmunology, gene therapy, metabolism, CRISPR gene editing/screen, iPSCs or animal models
-
-protein interaction that we had identified improves gene therapy approaches (Park, 2025). The MMR pathway is also involved in the response to endogenous and exogenous stresses that can lead to double-strand
-
type I IFN responses by genome-wide gene expression profiling. Experimental approach and training This project brings together immunology, infection biology, genetic manipulation of model organisms and
-
. This technique offers new opportunities for early diagnosis of retinal diseases and for testing innovative gene therapies. Within the project, we will develop new technologies to enhance the efficiency